Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/ELI-LILLY-AND-COMPANY-13401/news/Eli-Lilly-and-Company-gibt-positive-Topline-Ergebnisse-der-klinischen-Phase-3-Studien-zu-Surmount-OS-46456285/?utm_source=whatsapp&utm_medium=social&utm_campaign=share